Cargando…
Role of methylphenidate in the treatment of fatigue in advanced pancreatic cancer population
BACKGROUND: Fatigue is a common but devastating symptom for advanced pancreatic cancer (APC) patients. To date, no proven treatment exists. Methylphenidate (MPH) showed inconsistent results in treating other cancer related fatigue. We performed a retrospective study to assess MPH in ameliorating fat...
Autores principales: | Jiang, Zhenyang, Butler-Bowen, Harriet, Rodriguez, Teresa, Garcon, Marie C., Smith, Melissa Hennessey, Relias, Valerie, Saif, Muhammad Wasif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049564/ https://www.ncbi.nlm.nih.gov/pubmed/27708523 http://dx.doi.org/10.20524/aog.2016.0065 |
Ejemplares similares
-
Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma
por: SAIF, MUHAMMAD WASIF, et al.
Publicado: (2014) -
Treatment with Lanreotide Depot Following Octreotide Long-Acting Release Among Patients with Gastroenteropancreatic Neuroendocrine Tumors
por: Saif, Muhammad Wasif, et al.
Publicado: (2018) -
Imatinib-induced hyperbilirubinemia with UGT1A1 (*28) promoter polymorphism: first case series in patients with gastrointestinal stromal tumor
por: Saif, Muhammad Wasif, et al.
Publicado: (2016) -
Pancreatic Tuberculosis or Autoimmune Pancreatitis
por: Salahuddin, Ayesha, et al.
Publicado: (2014) -
Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance
por: Ogbonna, Onyekachi Henry, et al.
Publicado: (2013)